Table 1.
Commonly used strains, with genotypes. Citations indicate originally developed locations and/or application.
| Strain | Genotype | Ref(s) |
|---|---|---|
| BL21-Rosetta (DE3)a | F−ompT hsdSB(rB− mB−) gal dcm (DE3)a pRARE (Novagen) | [49,50] |
| BL21-Rosetta2 (DE3)a | F−ompT hsdSB(rB− mB−) gal dcm (DE3)a pRARE2 (Novagen) | [8,33,51] |
| BL21-Star (DE3)a | F−ompT hsdSB(rB−, mB−) gal dcm rne131 (DE3)a | [25,49,50] |
| BL21-Gold-dLac (DE3)a | F−ompT hsdSB(rB− mB−) dcm gal (DE3)aendA lacZYA | [14] |
| JS006 | MG1655 araC lacI | [52,53] |
| A19 | rna gdhA2 relA1 spoT metB1 | [11,50,54,55] |
| KC1 | A19 speA tnaA tonA endA sdaA sdaB met+ | [56] |
| KC6 | KC1 gshA | [57] |
| KG6-der. | KC6 rnb ackA+ef-tu+hchA+ibpA+ibpB+if-1+if-2+if-3+ | [58] |
| KGK10 | KC6 gorB trxB-HA | [[59], [60], [61]] |
| NMR1 | A19 endA met+ | [56] |
| NMR2 | A19 speA tnaA tonA endA met+ | [56] |
| NMR4 | A19 recD endA met+ | [62] |
| NMR5 | A19 lambda phage<>recBCD met+ | [62] |
| S30BL/Dna | BL21(DE3) dnaK/J+grpE+ | [63] |
| S30BL/DsbC | BL21(DE3) dsbC+ | [63] |
| S30BL/GroE | BL21(DE3) groEL/ES+ | [63] |
| S30OB | F−ompT hsdSB(rB− mB−) gal dcm lacY1 ahpC (DE3) gor522::Tn10 trxB (Novagen) | [63] |
| S30OB/Dna | S30OB dnaK/J+grpE+ | [63] |
| S30OB/DsbC | S30OB dsbC+ | [63] |
| S30OB/GroE | S30OB groEL/ES+ | [63] |
Each of these strains is available with and without DE3 modifications, which enables induction of T7 polymerase. Some studies use DE3 strains while others do not.